INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2020

Nicotinamide is reviewed as a low-cost, safe, evidence-based treatment for skin cancers, actinic keratosis, and bullous pemphigoid.

This review discusses nicotinamide (niacinamide), a form of vitamin B3 often confused with nicotinic acid (niacin). The authors examine its evidence as a low-cost oral treatment option for actinic keratosis, squamous cell carcinomas, basal cell carcinomas, and bullous pemphigoid. It details nicotinamide's favorable safety profile, distinguishes it from niacin, and addresses barriers to its integration into clinical practice along with practical guidance on recommendations and product availability.

Study type
Narrative review
Who was studied
Patients with dermatologic conditions considered for nicotinamide treatment
What was measured
Efficacy, safety, differences from niacin, and clinical integration

THE PAPER

Nicotinamide: An Update and Review of Safety & Differences from Niacin.

Huber R, Wong A. Skin Therapy Lett, 2020.

PubMed 33196157 ↗

CancerNutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.